BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS • Currently down 1.02 (-1.56%) in today's trading session

2 members of Congress have disclosed 8 trades in BioMarin Pharmaceutical Inc. (BMRN) via STOCK Act filings. The most recent disclosure was a sale by Josh Gottheimer on 18 October 2021. The most active traders have been Josh Gottheimer (7) and Gilbert Cisneros (1). Aggregate disclosed activity totals roughly $72.5K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

BioMarin Pharmaceutical Inc. is currently trading at $64.27, positioned at 69% of its 52-week range ($49.26 – $70.98).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Portfolio

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$64.27
24h Change
-1.02 (-1.56%)
52 Week Range
$49.26—$70.98
View on NASDAQ

BioMarin Pharmaceutical Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BMRN

Select to highlight on chart
6 transactions
Compliance: 75%
Josh Gottheimer18 Oct 202115 Nov 2021SaleStock$1,001 - $15,000N/A
Gilbert Cisneros30 Dec 202011 Jan 2021PurchaseStock$15,001 - $50,000N/A
Josh Gottheimer16 Oct 20205 Nov 2020PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer15 Sept 202013 Oct 2020SaleStock$1,001 - $15,000N/A
Josh Gottheimer16 Dec 20196 Jan 2020PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer11 Dec 20196 Jan 2020PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

No overview data available for this stock

Earnings

Next Report

Q3 2026

26 Oct

EPS Est.

$1.38

Rev. Est.

$1B

Days Until

59

Recent Quarters

Q2 20266 Aug
EPS$1.20
Beat 26.7%
Q1 20264 May
EPS$0.76
Miss 2.6%
Q4 202523 Feb
EPS$-0.24
Miss 241.7%
Q3 202527 Oct
EPS$-0.16
Miss 6.7%
Q2 20254 Aug
EPS$1.23
Beat 42.9%
Q1 20251 May
EPS$0.97
Beat 35.9%
Q4 202419 Feb
EPS$0.64
Beat 18.5%
Q3 202429 Oct
EPS$0.55
Beat 3.6%
Q2 20245 Aug
EPS$0.55
Beat 53.7%
Q1 202424 Apr
EPS$0.46
Beat 47.5%
Q4 202322 Feb
EPS$0.11
Miss 44.2%
Q3 20231 Nov
EPS$0.21
Miss 4.3%
Q2 202331 Jul
EPS$0.29
Beat 37.2%
Q1 202326 Apr
EPS$0.27
Beat 74.1%
Q4 202227 Feb
EPS$0.11
Beat 257.1%
Q3 202226 Oct
EPS$-0.04
Miss 233.3%
Q2 20223 Aug
EPS$0.15
Beat 355.6%
Q1 202227 Apr
EPS$0.63
Beat 196.5%
Q4 202123 Feb
EPS$-0.32
Beat 11.7%
Q3 202127 Oct
EPS$-0.20
Beat 20.0%
Q2 202128 Jul
EPS$0.23
Miss 23.3%
Q1 202129 Apr
EPS$0.10
Beat 242.9%
Q4 202025 Feb
EPS$0.12
Beat 171.4%
Q3 20205 Nov
EPS$4.01
Beat 1504.0%
Q2 20204 Aug
EPS$-0.16
Miss 60.0%
Q1 202029 Apr
EPS$0.45
Beat 800.0%
Q4 201926 Feb
EPS$0.08
Beat 319.2%
Q3 201923 Oct
EPS$0.31
Beat 416.7%
Q2 20191 Aug
EPS$-0.21
Miss 98.8%
Q1 201925 Apr
EPS$-0.32
Miss 68.4%
Q4 201821 Feb
EPS$-0.07
Miss 170.0%
Q3 201825 Oct
EPS$-0.07
Miss 153.8%
Q2 20182 Aug
EPS$-0.09
Miss 152.9%
Q1 201825 Apr
EPS$-0.25
Miss 292.3%
Q4 201722 Feb
EPS$-0.30
Miss 25.0%
Q3 201726 Oct
EPS$-0.07
Beat 50.0%
Q2 20172 Aug
EPS$-0.21
Beat 4.5%
Q1 20174 May
EPS$-0.09
Beat 69.0%
Q4 201623 Feb
EPS$-0.53
Miss 39.5%
Q3 201627 Oct
EPS$-0.26
Beat 33.3%
Q2 20164 Aug
EPS$-2.61
Miss 411.8%
Q1 201628 Apr
EPS$-0.53
Beat 36.9%
Q4 201525 Feb
EPS$0.39
Miss 60.6%
Q3 201529 Oct
EPS$-0.57
Beat 12.3%
Q2 20153 Aug
EPS$-0.51
Beat 3.8%
Q1 201530 Apr
EPS$-0.38
Beat 28.3%
Q4 201425 Feb
EPS$-0.47
Beat 20.3%
Q3 201423 Oct
EPS$0.05
Beat 122.7%
Q2 201430 Jul
EPS$-0.22
Beat 47.6%
Q1 20141 May
EPS$-0.33
Beat 28.3%
Q4 201326 Feb
EPS$-0.43
Miss 26.5%
Q3 201324 Oct
EPS$-0.38
Miss 26.7%
Q2 201325 Jul
EPS$-0.15
Beat 48.3%
Q1 201325 Apr
EPS$-0.31
Miss 6.9%
Q4 201221 Feb
EPS$-0.43
Miss 59.3%
Q3 201225 Oct
EPS$-0.04
Beat 80.0%
Q2 20121 Aug
EPS$-0.27
Miss 28.6%
Q1 201226 Apr
EPS$-0.21
Miss 50.0%
Q4 201116 Feb
EPS$-0.23
Miss 109.1%
Q3 201127 Oct
EPS$-0.14
Miss 27.3%
Q2 201128 Jul
EPS$-0.05
Beat 54.5%
Q1 201128 Apr
EPS$-0.04
Beat 60.0%
Q4 201017 Feb
EPS$-0.11
Miss 450.0%
Q3 201028 Oct
EPS$1.68
Beat 16900.0%
Q2 20102 Aug
EPS$-0.00
Miss 115.7%
Q1 201029 Apr
EPS$0.01
Q4 200923 Feb
EPS$0.05
Beat 400.0%
Q3 200928 Oct
EPS$0.06
Beat 500.0%
Q2 200930 Jul
EPS$0.01
Beat 200.0%
Q1 200930 Apr
EPS$-0.13
Miss 8.3%
Q4 200818 Feb
EPS$0.21
Miss 19.2%
Q3 200828 Oct
EPS$0.01
Miss 66.7%
Q2 20085 Aug
EPS$0.04
Beat 33.3%
Q1 200829 Apr
EPS$0.02
Beat 140.0%
Q4 200726 Feb
EPS$0.03
Miss 25.0%
Q3 20071 Nov
EPS$-0.05
Beat 50.0%
Q2 20077 Aug
EPS$-0.04
Beat 33.3%
Q1 200730 Apr
EPS$-0.10
Beat 9.1%
Q4 200620 Feb
EPS$-0.11
Beat 15.4%
Q3 20061 Nov
EPS$-0.08
Beat 38.5%
Q2 20062 Aug
EPS$-0.02
Beat 81.8%
Q1 20063 May
EPS$-0.13
Beat 38.1%
Q4 200523 Feb
EPS$-0.20
Beat 9.1%
Q3 20051 Nov
EPS$-0.21
Beat 25.0%
Q2 20051 Aug
EPS$-0.33
Beat 5.7%
Q1 20055 May
EPS$-0.35
Beat 0.0%
Q4 200423 Feb
EPS$-0.23
Beat 30.3%
Q3 20043 Nov
EPS$-0.40
Miss 11.1%
Q2 20049 Aug
EPS$-0.28
Beat 3.5%
Q1 20044 May
EPS$-0.31
Beat 0.0%
Q4 20033 Feb
EPS$-0.40
Miss 5.3%
Q3 20034 Nov
EPS$-0.33
Beat 15.4%
Q2 20035 Aug
EPS$-0.14
Beat 12.5%
Q1 20035 May
EPS$-0.35
Miss 25.0%
Q4 20029 Feb
EPS$-0.36
Miss 2.9%
Q3 200231 Oct
EPS$-0.32
Miss 3.2%
Q2 20021 Aug
EPS$-0.27
Beat 6.9%
Q1 20027 May
EPS$-0.51
Miss 54.5%
Q4 200125 Feb
EPS$-0.34
Miss 13.3%
Q3 200126 Oct
EPS$-0.26
Beat 13.3%
Q2 200127 Jul
EPS$-0.30
Miss 15.4%
Q1 200127 Apr
EPS$-0.26
Beat 0.0%
Q4 200022 Feb
EPS$-0.28
Beat 15.2%
Q3 200030 Oct
EPS$-0.23
Beat 20.7%
Q2 200028 Jul
EPS$-0.19
Beat 29.6%
Q1 200028 Apr
EPS$-0.34
Miss 30.8%
Q4 199918 Feb
EPS$-0.26
Beat 0.0%
Q3 199915 Nov
EPS$-0.24
Miss 20.0%
Q3 19991 Nov
EPS$-0.24
Miss 9.1%
Q4 199831 Mar
EPS$-0.75

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

LLY

Eli Lilly and Company

74
$1172.13-3.97 (-0.34%)
Healthcare
2 politicians both hold this
Same sector: Healthcare
2 politicians
View Stock

JNJ

Johnson & Johnson

74
$266.38+0.62 (+0.23%)
Healthcare
2 politicians both hold this
Same sector: Healthcare
2 politicians
View Stock

MSFT

Microsoft Corporation

69
$516.37+11.31 (+2.24%)
Technology
2 politicians both hold this
$34M in total holdings
2 politicians
View Stock

Frequently Asked Questions about BMRN

Which members of Congress have traded BMRN?
2 members of Congress have disclosed 8 trades in BioMarin Pharmaceutical Inc. (BMRN) under the STOCK Act. The most active traders are Josh Gottheimer and Gilbert Cisneros.
When was BMRN most recently disclosed by Congress?
The most recent BMRN disclosure was a sale by Josh Gottheimer on 18 October 2021.
What is the total disclosed congressional trading volume for BMRN?
Members of Congress have disclosed approximately $72.5K in BMRN purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in BMRN?
This BMRN page updates as soon as new STOCK Act disclosures are filed for BioMarin Pharmaceutical Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.